Safety and activity of saquinavir in HIV infection by Kitchen, V.S., Skinner, C., Ariyoshi, K., Weber, J.N., Pinching, A.J., Lane, E.A., Duncan, I.B., Burckhardt, J., Burger, H.U., Bragman, K.

Get full text

Denis Neville Baron by Bragman, Keith

Get full text

Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and Carboplatin by Mangioni, C., Bolis, G., Pecorelli, S., Bragman, K., Epis, A., Favalli, G., Gambino, A., Landoni, F., Presti, M., Torri, W., Vassena, L., Zanaboni, F., Marsoni, S.

Get full text

Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir by Ives, K J, Jacobsen, H, Galpin, S A, Garaev, M M, Dorrell, L, Mous, J, Bragman, K, Weber, J N

Get full text

Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals by Darbyshire, JH

Get full text

Randomised, Multicentre Phase III Study of Saquinavir plus Zidovudine plus Zalcitabine in Previously Untreated or Minimally Pretreated HIV-Infected Patients by Stellbrink, Hans-J??rgen, Hawkins, David A., Clumeck, Nathan, Cooper, David A., Myers, Robert, Delfraissy, J.-F., Gill, M. John, Ramirez-Ronda, Carlos, Vella, Stefano, Salgo, Miklos, Bragman, Keith

Get full text

Emerging proteinase inhibitors by Kitchen, Valerie, Stewart, Fran, Bragman, K., Weber, Jonathan

Get full text

Cytotoxicity of Antibody-Directed Liposomes That Recognize Two Receptors on K562 Cells by Bragman, Keith S., Heath, Timothy D., Papahadjopoulos, Demetrios

Get full text

HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial by Brun-Vezinet, Francoise, Boucher, Charles, Loveday, Clive, Descamps, Diane, Fauveau, Veronique, Izopet, Jacques, Jeffries, Don, Kaye, Steve, Krzyanowski, Corinne, Nunn, Andrew, Schuurman, Rob, Seigneurin, Jean-Marie, Tamalet, Catherine, Tedder, Richard, Weber, Jonathan, Weverling, Gerrit-Jan

Get full text

Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside by DHALIWAL, H. S, SHANNON, M. S, BARNETT, M. J, PRENTICE, H. G, BRAGMAN, K, MALPAS, J. S, LISTER, T. A

Get full text

Evidence for prolonged clinical benefit from initial combination antiretroviral therapy: Delta extended follow‐up by Delta Coordinating Committee, Delta Coordinating Committee

Get full text

New Methodology for Liposome Targeting to Specific Cells by PAPAHADJOPOULOS, DEMETRIOS, HEATH, TIMOTHY, BRAGMAN, KEITH, MATTHAY, KATHERINE

Get full text

Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir by IVES, K. J, JACOBSEN, H, GALPIN, S. A, GARAEV, M. M, DORRELL, L, MOUS, J, BRAGMAN, K, WEBER, J. N

Get full text

Disease Progression Modeling in Chronic Obstructive Pulmonary Disease by Young, Alexandra L, Bragman, Felix J S, Rangelov, Bojidar, Han, MeiLan K, Galbán, Craig J, Lynch, David A, Hawkes, David J, Alexander, Daniel C, Hurst, John R

Get full text

Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011 by Ison, Catherine A, Prof, Town, Katy, MSc, Obi, Chinelo, MSc, Chisholm, Stephanie, PhD, Hughes, Gwenda, PhD, Livermore, David M, Prof, Lowndes, Catherine M, PhD

Get full text

Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales by Chisholm, Stephanie A., Alexander, Sarah, Desouza-Thomas, Leah, Maclure-Webster, Elisabeth, Anderson, John, Nichols, Tom, Lowndes, Catherine M., Ison, Catherine A.

Get full text

Disease Progression Modeling in Chronic Obstructive Pulmonary Disease by Young, Alexandra L., Bragman, Felix J. S., Rangelov, Bojidar, Han, MeiLan K., Galbán, Craig J., Lynch, David A., Hawkes, David J., Alexander, Daniel C., Hurst, John R., Crapo, James D., Silverman, Edwin K., Make, Barry J., Regan, Elizabeth A., Beaty, Terri, Begum, Ferdouse, Castaldi, Peter J., Cho, Michael, DeMeo, Dawn L., Boueiz, Adel R., Foreman, Marilyn G., Halper-Stromberg, Eitan, Hayden, Lystra P., Hersh, Craig P., Hetmanski, Jacqueline, Hobbs, Brian D., Hokanson, John E., Laird, Nan, Lange, Christoph, Lutz, Sharon M., McDonald, Merry-Lynn, Parker, Margaret M., Qiao, Dandi, Wan, Emily S., Won, Sungho, Sakornsakolpat, Phuwanat, Prokopenko, Dmitry, Al Qaisi, Mustafa, Coxson, Harvey O., Gray, Teresa, Han, MeiLan K., Hoffman, Eric A., Humphries, Stephen, Jacobson, Francine L., Judy, Philip F., Kazerooni, Ella A., Kluiber, Alex, Lynch, David A., Newell, John D., Ross, James C., Estepar, Raul San Jose, Schroeder, Joyce, Sieren, Jered, Stinson, Douglas, Stoel, Berend C., Tschirren, Juerg, Van Beek, Edwin, van Ginneken, Bram, van Rikxoort, Eva, Washko, George, Wilson, Carla G., Jensen, Robert, Everett, Douglas, Crooks, Jim, Moore, Camille, Strand, Matt, Hughes, John, Kinney, Gregory, Pratte, Katherine, Young, Kendra A., Bhatt, Surya, Bon, Jessica, Martinez, Carlos, Murray, Susan, Soler, Xavier, Bowler, Russell P., Kechris, Katerina, Banaei-Kashani, Farnoush, Curtis, Jeffrey L., Martinez, Carlos H., Pernicano, Perry G., Hanania, Nicola, Alapat, Philip, Atik, Mustafa, Bandi, Venkata, Boriek, Aladin, Guntupalli, Kalpatha, Guy, Elizabeth, Nachiappan, Arun, Parulekar, Amit, Barr, R. Graham, Austin, John, D’Souza, Belinda, Pearson, Gregory D. N., Rozenshtein, Anna, Thomashow, Byron, MacIntyre, Neil, McAdams, H. Page, Washington, Lacey, McEvoy, Charlene, Tashjian, Joseph

Get full text

Can Previous First-Line Therapies for Neisseria gonorrhoeae Be Targeted to Specific Patient Subgroups to Treat Gonorrhea? by Town, Katy, Lowndes, Catherine M., Hughes, Gwenda, Obi, Chinelo, Chisholm, Stephanie, Ison, Catherine A.

Get full text